RT Journal Article
SR Electronic
T1 Follow-up of infants hospitalized for bronchiolitis. Clinical factors that determine their evolution
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP PA4182
DO 10.1183/13993003.congress-2015.PA4182
VO 46
IS suppl 59
A1 Zepeda, Guillermo
A1 Díaz, Patricia
A1 Pinto, Ricardo
A1 Gaggero, Aldo
A1 Uasapud, Paola
YR 2015
UL http://erj.ersjournals.com/content/46/suppl_59/PA4182.abstract
AB Background: It has been linked respiratory viral infection in infancy with more likelihood of developing asthma and atopy. The aim of this ongoing study is to analyze the clinical markers of patients hospitalized for bronchiolitis that determine their evolution.Patients and methods: Previously healthy infants hospitalized by bronchiolitis during 2009-2011. We determined in the nasopharyngeal aspirate the viral etiology by qPCR. Clinical record at the hospitalization and clinical follow up at the age of 4-5 years. Results are expressed in medians, mean and range. Mann-Whitney nonparametric statistical analysis.Results: 33 patients followed until now. The median age of hospitalization was 3.5 months. Etiology: respiratory syncytial virus (RSV) 49%, co-infection RSV and rhinovirus (RV) 33%, other viruses 18%. Of the total of patients,11(33%) are currently children with recurrent wheezing (RW). There was no difference between the RW group versus non RW group in: age of hospitalization; days of hospitalization, oxygen therapy, fever or cough; infection severity; personal or family atopy; presence of older siblings; or the single or dual infection. It stands out the high level of intradomiciliary contamination given by second-hand smoke (67%) and heating by combustion (70%) in the total of patients.Conclusions: The infection by RSV or co-infection of RSV and RV did not worsen the clinical evolution. The RW preschool children had no further development of atopy. The bronchial inflammation of our RW preschool children may be explained by other factors.Fondecyt 1120411 Project was approved by ethics committees of Roberto del Rio Hospital and Faculty of Medicine, University of Chile.